MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.
about
Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi exportmicroRNAs: Emerging Targets Regulating Oxidative Stress in the Models of Parkinson's DiseaseMicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological DiseasesThe involvement of microRNAs in neurodegenerative diseasesNeuronal dark matter: the emerging role of microRNAs in neurodegenerationEpigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalitiesA Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma CellsProtective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity.Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathologyIdentification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.RNA metabolism in the pathogenesis of Parkinson׳s diseaseExpression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice.Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene networkMicroRNA‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1.Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer diseaseGenotype and age at Parkinson disease diagnosis.Computational Prediction of Alzheimer's and Parkinson's Disease MicroRNAs in Domestic AnimalsLRRK2: an éminence grise of Wnt-mediated neurogenesis?RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis.LRRK2: cause, risk, and mechanism.MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2BIdentification of therapeutic targets for Parkinson's disease via bioinformatics analysis.Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell.Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.MicroRNA machinery in Parkinson's disease: a platform for neurodegenerative diseases.microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.microRNAs and Neurodegenerative Diseases.MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?Epigenetic mechanisms in neurogenesis.Epigenetic regulation in Parkinson's disease.Molecular changes in the postmortem parkinsonian brain.MicroRNAs in glaucoma and neurodegenerative diseases.The roles of non-coding RNAs in Parkinson's disease.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.miRNAs as biomarkers of neurodegenerative disorders.LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1).
P2860
Q24303851-918C0587-7A90-4A9E-9346-09146078EFA4Q26738440-76B0535F-8D63-404B-A7D0-D356A97D563AQ26744819-4F577BD4-B1F3-45F7-9635-3AD404A6C62BQ26858788-112165AC-D94B-4A07-8D58-6BF8B7889E4EQ26859224-FE8BBCDB-0F1B-4659-B907-9046623B5949Q27023811-52FE4E31-9D8B-4A77-B578-837D16D365D7Q28551285-96D648B7-9DF5-4EC1-B279-5E7946C264CEQ29347547-56313840-7B53-46DC-AA95-B4B3294C4414Q33567669-C153B0AE-DA5C-4FB6-95DE-088686325C3BQ33732095-AFB963EF-AE68-41AE-BB07-E07C8F20BBD7Q33797449-95FF4653-16E5-4422-837A-9D9CC3ED19DFQ34175642-DB813BCF-1C8C-41F4-8BD3-3E960FED0BC3Q34723024-EB054C4D-8038-4C9C-B161-8BE4C6E0D08DQ35654904-A848E700-426E-4392-977E-C87706413BF9Q36089751-B37A9281-37D6-4FA6-B8B0-60F0F4ADC484Q36545671-0E737F48-E413-4D9D-8C88-63882EDF34BDQ36729049-5CF632F0-12E4-405B-903C-3724B0F21E51Q36855169-4B69D343-92B5-469B-A2DA-9DE2A7A88FA4Q36888947-516C49AD-76DB-4FB7-9C33-5D38D32221D4Q37325908-6D8915AD-799E-4027-8841-B679370858B6Q37635000-4FCEFA08-827D-4D84-8CB0-64B956A3B248Q37702119-B5BA02BE-838B-4FFE-8635-D606CFB8F870Q37707469-8459DFE1-98C8-4DBC-AF5D-F2DD7DB84B94Q37720038-127675DF-6856-4693-B3AD-B30FFF057E65Q38224066-22E42B1C-D66B-4907-9924-5F7A01FA04B0Q38445454-13493F61-C570-4FB0-B5FD-F8BC39635321Q38584755-9AA9B2F2-EC73-4585-BB33-572C76370E73Q38635154-1A0D7C9B-A9DE-4684-B217-A78D38F85DDBQ38648154-7C255713-2E11-4DF7-B46C-65E02E634EA0Q38668251-6F3346BA-E28B-47E7-A1F3-16393095042BQ38843644-9C13871E-1AF7-4BEA-9BB7-11679EAEBEA2Q38873613-A1CA675E-C29A-4780-B2D2-ACA2A6E3E435Q38881221-F1E11D29-BE5B-409F-AD8E-E17B09700303Q38887346-5DC4B252-0509-46C9-8C60-91AD41FA4E8DQ38895922-2D995A42-A951-4321-97F3-E92A7F8F9F9FQ38918848-EA98FF5D-AE25-4A5C-836D-3F4144962BFDQ39010887-474837C7-D0AA-4227-A21D-3F58055C0DE6Q39104808-F75876CD-1C13-49C1-8925-5E3CD5BCE4E8Q39136594-92766C14-8B03-4A20-BE15-B1FA716BC873Q39561853-C88CA0AE-7136-4E39-9890-95CD6555C992
P2860
MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.
@ast
MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.
@en
type
label
MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.
@ast
MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.
@en
prefLabel
MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.
@ast
MicroRNA-205 regulates the exp ...... -rich repeat kinase 2 protein.
@en
P2093
P2860
P50
P356
P1476
MicroRNA-205 regulates the exp ...... e-rich repeat kinase 2 protein
@en
P2093
Chengsong Xie
Guoxiang Liu
Hyun Jin Cho
Jinhui Ding
Juan C Troncoso
Loukia Parisiadou
Renée Vancraenenbroeck
P2860
P304
P356
10.1093/HMG/DDS470
P577
2012-11-02T00:00:00Z